CNTA vs WY · $6.15B cap vs P/E 43, rev $3.59B
Centessa Pharmaceuticals PLC ADR (CNTA) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
CNTA currently screens at market cap $6.15B. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the CNTA and WY stock pages for the full models.
Not investment advice.